Improving heart failure care in Denver
Part of Heart & circulation clinical trials.
This study aims to improve heart failure treatment for people who have limited access to care in Denver. If you have heart failure with reduced pumping ability and are a patient in the Denver Health system, this trial may help find better ways to manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have heart failure with reduced pumping strength (ejection fraction 40% or less).
- You receive your medical care within the Denver Health and Hospital Authority system.
- Your kidney function is not severely low (eGFR at least 25) and you are not on dialysis.
- You do not have severe liver disease (cirrhosis).
- You can understand and agree to join the study, and you speak English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a pharmacist can help adjust your heart failure medications step by step to reach the best doses for you. It aims to make sure you get the most effective treatment for your heart condition.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This trial uses a national heart failure registry to see if a new way of monitoring treatment can help optimize therapy for people with heart failure and reduced ejection fraction (a weak heart pump). It may lead to better medication adjustments over time.
This study tests a new way to manage heart failure through regular outpatient clinic visits and remote monitoring, aiming to reduce hospital readmissions and improve quality of life. It compares the new ambulatory care model with standard care to see if it helps patients stay healthier at home.
This trial tests whether safely increasing the dose of standard heart failure medications can improve outcomes in people with a weak heart pump, while keeping a close eye on kidney function. It may be a good fit if you have heart failure with reduced ejection fraction and are not yet on the highest recommended doses of your medicines.
This study tests whether a program that connects you with community health workers and your care team can help you manage heart failure better. It looks at things like your living situation, medical needs, and social support to make your care more fair and personalized.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.